Kevin C. Tang, Chief Executive Officer, Chief Financial Officer, Officer, Chief Operating Officer at Odonate Therapeutics, Inc. (ODT), bought 15,286 shares at $22.16 ($344K) on 2019-06-03, disclosed to the SEC on 2019-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.16 | 7,859 | $174K | 50.6% |
| 2 | $22.86 | 7,427 | $170K | 49.4% |
| Total | $22.50 avg | 15,286 | $344K | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |